Menu Back toFrom Opportunity to Strategy: Introducing Intelligent Automation Technologies within Pharmacovigilance for the ICSR Process

DIA 2021 Global Annual Meeting

From Opportunity to Strategy: Introducing Intelligent Automation Technologies within Pharmacovigilance for the ICSR Process

Session Chair(s)

Raymond Kassekert, MBA

Raymond Kassekert, MBA

  • Senior Director PV Systems
  • GSK, United States
Intelligent automation can transform the ICSR process. We discuss how to pair opportunities with available technologies for this process, and how a validation strategy may vary based on the proposed automation for a given ICSR process step.
Learning Objective : Recognize available PV automation technologies as they relate to opportunities and the current PV technology landscape within the ICSR process; Describe how to plan future use of intelligent automation based on risks, benchmarking, and potential benefit; Describe how to educate colleagues on possible opportunities, areas worth exploring for further transformation, possible technology solutions, and validation strategy.

Speaker(s)

Sameen Desai, MBA, MS

Introducing Intelligent Automation Technologies within Pharmacovigilance for the ICSR Process

Sameen Desai, MBA, MS

  • Executive Director, IT Worldwide Patient Safety
  • Bristol-Myers Squibb Company, United States
Neal Grabowski, MBA, MS

Introducing Intelligent Automation Technologies within Pharmacovigilance for the ICSR Process

Neal Grabowski, MBA, MS

  • TransCelerate IAO Workstream Lead; Head, Signal Management
  • Sanofi, United States
Griselda Saldana, MSc

Introducing Intelligent Automation Technologies within Pharmacovigilance for the ICSR Process

Griselda Saldana, MSc

  • Director, Global Safety, Systems and Information Management
  • California, United States